DENMARK - Venture-backed Exiqon enters co-development agreement

Venture-backed Exiqon A/S, a leading supplier of high-value gene expression analysis products, and Luminex® Corporation have signed an agreement to co-develop and commercialise microRNA products. Exiqon will develop and manufacture microRNA products on behalf of the Luminex Bioscience Group based on Luminex’s xMAP® technology and Exiqon’s Locked Nucleic Acid technology.